Real-time enrollment status for this pancreatic adenocarcinoma metastatic clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:21 AM UTC
| NCT Number | NCT04150042 |
| Recruiting Status | Recruiting |
| Condition | Pancreatic Adenocarcinoma Metastatic |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 2 sites in the US |
| Sponsor | General Oncology, Inc. |
| Last Updated on CT.gov | January 29, 2026 (Jan 29, 2026) |
As of August 31, 2026: Clinical trial NCT04150042 is currently recruiting participants. This phase1 study for pancreatic adenocarcinoma metastatic is actively seeking new participants at 2 locations across the United States. The study is sponsored by General Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04150042 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04150042 was last updated Jan 29, 2026 (January 29, 2026). HelloStudys verifies this status automatically.